FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning FDA extends its use of CluePoints to include ...
FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials To discover signals of suspected misbehavior, the FDA and other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback